American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)

美国心脏协会烟草管制和成瘾中心 (A-TRAC)

基本信息

  • 批准号:
    8737954
  • 负责人:
  • 金额:
    $ 397.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-19 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This project is to build and develop a Tobacco Regulation and Addiction Center at the American Heart Association (AHA). This virtual Center will be a network of consortia between AHA and several leading academic institutions. It will house programs of multidisciplinary research that will inform the manufacture, distribution and marketing of tobacco products related to the regulatory authority of the FDA. Center investigators will study the cardiovascular toxicity of tobacco products and the relationship between tobacco product use and subclinical progression of cardiovascular disease to identify sensitive and robust biomarkers of cardiovascular injury related to tobacco product exposure. These studies will help to identify the relative sensitivity of specific domains of cardiovascular injury that are sensitive to tobacco exposure and facilitate the identification of harmful and potentially harmful constituents of current, new and emerging tobacco products that cause cardiovascular injury and how the impact of these constituents on cardiovascular disease outcomes could be measured. In cohorts of varying ethnicities, behavior, perceptions, and attitudes regarding tobacco products will be studied to identify which communications channels are used by vulnerable populations to obtain information about tobacco products, and which strategies are likely to be effective in discouraging initiation and continuation of tobacco use. The Center will also provide comprehensive education, state-of-the-art training in tobacco regulatory science and foster the development of independent research careers of junior investigators. Research in the Center will be supported by facilities/cores that will provide assessments and characterization of exposure to tobacco products and unified measurements of biomarkers and validated indices of cardiovascular injury. The administrative core of the Center will provide scientific, administrative and logistic oversight to all aspects of the Center and coordinate integrative team science focused on addressing the research priorities of the FDA. The Center will be well-poised to undertake strong and coordinated research projects in response to new developments and conduct collaborative research with other Centers in the Tobacco Centers of Regulatory Science. RELEVANCE: Research supported by the AHA-Tobacco Regulation and Addiction Center (A-TRAC) will aid the development and evaluation of tobacco product regulation by the FDA and thereby contribute to the protection of public health and reduction of tobacco-related disease, disability and death.
描述(由申请人提供):该项目旨在在美国心脏协会(AHA)建立和开发一个烟草管制和成瘾中心。该虚拟中心将成为 AHA 和几个领先学术机构之间的联盟网络。它将容纳多学科研究项目,为与 FDA 监管机构相关的烟草产品的制造、分销和营销提供信息。中心研究人员将研究烟草产品的心血管毒性以及烟草产品使用与心血管疾病亚临床进展之间的关系,以确定与烟草产品暴露相关的心血管损伤的敏感且稳健的生物标志物。这些研究将有助于确定对烟草暴露敏感的心血管损伤特定领域的相对敏感性,并有助于识别当前、新型和新兴烟草产品中导致心血管损伤的有害和潜在有害成分,以及这些成分的影响如何可以测量心血管疾病的结果。在不同种族的群体中,将对烟草产品的行为、看法和态度进行研究,以确定弱势群体使用哪些沟通渠道来获取有关烟草产品的信息,以及哪些策略可能有效阻止开始和继续吸烟使用。该中心还将提供烟草监管科学方面的全面教育和最先进的培训,并促进初级研究人员独立研究职业的发展。该中心的研究将得到设施/核心的支持,这些设施/核心将提供烟草制品暴露的评估和表征以及生物标志物的统一测量和心血管损伤的验证指数。该中心的行政核心将为中心的各个方面提供科学、行政和后勤监督,并协调专注于解决 FDA 的研究重点的综合团队科学。该中心将做好准备,开展强有力的、协调一致的研究项目,以应对新的发展,并与烟草监管科学中心的其他中心开展合作研究。 相关性:由 AHA 烟草监管和成瘾中心 (A-TRAC) 支持的研究将有助于 FDA 制定和评估烟草产品监管,从而有助于保护公众健康并减少与烟草相关的疾病、残疾和死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aruni Bhatnagar其他文献

Aruni Bhatnagar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aruni Bhatnagar', 18)}}的其他基金

Diversity supplement to Urban Greenness and Cardiovascular Health
城市绿化与心血管健康的多样性补充
  • 批准号:
    10362208
  • 财政年份:
    2021
  • 资助金额:
    $ 397.25万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10208899
  • 财政年份:
    2018
  • 资助金额:
    $ 397.25万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10452733
  • 财政年份:
    2018
  • 资助金额:
    $ 397.25万
  • 项目类别:
Urban Greenness and Cardiovascular Health
城市绿化与心血管健康
  • 批准号:
    10381702
  • 财政年份:
    2018
  • 资助金额:
    $ 397.25万
  • 项目类别:
Urban Greenness and Cardiovascular Health
城市绿化与心血管健康
  • 批准号:
    9902454
  • 财政年份:
    2018
  • 资助金额:
    $ 397.25万
  • 项目类别:
Diversity Supplement to Urban Greenness and Cardiovascular Health
城市绿化和心血管健康的多样性补充
  • 批准号:
    10598172
  • 财政年份:
    2018
  • 资助金额:
    $ 397.25万
  • 项目类别:
Project 1 - Cardiometabolic Injury due to VOCs
项目 1 - VOC 引起的心脏代谢损伤
  • 批准号:
    10354689
  • 财政年份:
    2017
  • 资助金额:
    $ 397.25万
  • 项目类别:
Project 1 - Cardiometabolic Injury due to VOCs
项目 1 - VOC 引起的心脏代谢损伤
  • 批准号:
    10693801
  • 财政年份:
    2017
  • 资助金额:
    $ 397.25万
  • 项目类别:
ConProject-006
ConProject-006
  • 批准号:
    10225162
  • 财政年份:
    2013
  • 资助金额:
    $ 397.25万
  • 项目类别:
ConProject-004
ConProject-004
  • 批准号:
    10225161
  • 财政年份:
    2013
  • 资助金额:
    $ 397.25万
  • 项目类别:

相似海外基金

Optimizing Cardiovascular Preventive Care for Women following Hypertensive Disorders of Pregnancy.
优化妊娠期高血压疾病女性的心血管预防护理。
  • 批准号:
    10449470
  • 财政年份:
    2022
  • 资助金额:
    $ 397.25万
  • 项目类别:
Optimizing Cardiovascular Preventive Care for Women following Hypertensive Disorders of Pregnancy.
优化妊娠期高血压疾病女性的心血管预防护理。
  • 批准号:
    10631132
  • 财政年份:
    2022
  • 资助金额:
    $ 397.25万
  • 项目类别:
Implementing Shared Decision Making (SDM) for Individualized CV Prevention (SDM4IP)
实施共享决策 (SDM) 以实现个体化心血管预防 (SDM4IP)
  • 批准号:
    10392952
  • 财政年份:
    2020
  • 资助金额:
    $ 397.25万
  • 项目类别:
Implementing Shared Decision Making (SDM) for Individualized CV Prevention (SDM4IP)
实施共享决策 (SDM) 以实现个体化心血管预防 (SDM4IP)
  • 批准号:
    10611866
  • 财政年份:
    2020
  • 资助金额:
    $ 397.25万
  • 项目类别:
Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
临床转介体力活动预防心血管代谢疾病的进展
  • 批准号:
    10175021
  • 财政年份:
    2020
  • 资助金额:
    $ 397.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了